AlphAIAlphAI — Financial news for AI agents
SEC EDGAR 6-KAUG 212 min read$DDL

Dingdong (Cayman) Ltd (DDL): Financial results for Q2 2026

Dingdong (Cayman) Ltd (DDL) furnished an SEC Form 6-K — earnings release. Exhibit Index Exhibit No. Description Exhibit 99.1 Dingdong (Cayman) Limited Announces Second Quarter 2026 Financial Results SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the

Original reporting
SEC EDGAR 6-K
Published Aug 21, 2026, 10:28 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 28, 2026, 6:45 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$DDL
Bullish
high confidence
Mentioned
$DDL
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 6-K
Decision brief

The 30-second read

$DDLBullishHigh
01

Why it matters

The earnings beat and profitability trend suggest near‑term buying pressure, while the pending transaction adds conditional upside.

02

Market read

Strong earnings and a high‑profile divestiture make DDL a notable short‑term trade idea.

03

What to watch

Potential margin pressure from rising fulfillment costs if expansion outpaces efficiency gains.

Relevance 7/10Novelty 8/10Timing: after‑hours release on Aug 21, 2026

Background

Dingdong (Cayman) Ltd (DDL) filed a Form 6‑K reporting its Q2 2026 financial results, highlighting growth and a pending sale of its China business to Meituan.

Company-level read

Ticker impact

$DDLBullishHigh confidence
Context

Q2 2026 earnings release showing 11.8% YoY GMV growth, 153.5% net income increase and pending divestiture to Meituan.

Expected impact

Potential 5‑10% price rise in the next trading session, with further upside if the Meituan deal closes.

Evidence & confidence

Revenue and profit beat expectations, consistent growth trend, and a high‑profile divestiture pending regulatory approval.

Market effects

Sector

Positive signal for Chinese e‑commerce and grocery delivery sector, may lift peers.

Regional

Supports broader optimism in China's tech and consumer services markets.

Global

Limited to investors with exposure to Chinese growth stocks; modest global impact.

Counterpoint

What could challenge this read

Regulatory approval risk for the Meituan divestiture could delay value realization.

Key entities

  • Company
    Dingdong (Cayman) Ltd

    Chinese fresh grocery e‑commerce platform reporting Q2 2026 results.

  • Company
    Meituan

    Potential acquirer of Dingdong's China business.

Read at source← All news

Related articles

AUG 20
$DDLHighAI 8/10

Dingdong (Cayman) Limited Announces Second Quarter 2026 Financial Results

Dingdong (Cayman) Limited (NYSE: DDL) reported Q2 2026 financial results, with GMV up 11.8% YoY to RMB7,265.3M (US$1,070.8M) and net income of RMB271.7M (US$40.0M). The company saw its tenth consecutive quarter of profitability. CEO Song Wang attributed growth to increased ordering users and order frequency. The company is in the process of divesting its China business to Meituan, pending regulatory approval.

prnewswire.com2 min
OCT 28
$FLEXHighAI 9/10

FLEX REPORTS SECOND QUARTER FISCAL 2027 RESULTS

FLEX LTD. (FLEX) filed an SEC Form 8-K — Results of Operations and Financial Condition. P R E S S R E L E A S E EXHIBIT 99.1 FLEX REPORTS SECOND QUARTER FISCAL 2027 RESULTS • Reported Q2 net sales of $8.5 billion, up 25% versus the prior year. • Delivered Q2 GAAP operating margin of 4.9%, and adjusted operating margin of 7.1%. • Reported Q2 GAAP EPS of $0.70, and re

SEC EDGAR 8-K2 min
OCT 28
$BIIBHighAI 8/10

Biogen Slips To Loss In Q3; Raises Low-end Of FY26 Earnings View

Biogen (BIIB) reported a Q3 loss of $20.6M, down from a $466.5M profit last year, despite an 11% revenue increase to $2.8B. Adjusted EPS was $2.62, down from $4.81. The loss was driven by transaction-related charges. Biogen raised its low-end FY26 EPS outlook to $12.20-$13.00, up from $12.00-$13.00. Shares were down 0.29% in premarket trading.

rttnews.com2 min
OCT 28
$NIHighAI 8/10

NiSource Q3 Net Income Rises

NiSource (NI) reported Q3 net income of $129.5M, or $0.27 per share, up from $94.7M, or $0.20 per share, in 2025. Revenues rose to $1.35B. The company narrowed 2026 EPS guidance to the upper half of $2.02-$2.07 and expects 2027 EPS of $2.22-$2.30. It extended its capital plan through 2033, with $40B in expenditures expected to drive 9-10% investment base growth and 10-11% EPS growth annually from 2027-2033.

rttnews.com2 min
OCT 28
$BLKBMed

Blackbaud Announces 2026 Third Quarter Financial Results

BLACKBAUD INC (BLKB) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 PRESS RELEASE Blackbaud Announces 2026 Third Quarter Financial Results Blackbaud Expands AI Leadership Through Numerous Innovation Announcements at bbcon User Conference Charleston, S.C. (October 28, 2026) — Blackbaud (NASDAQ: BLKB), the world's leading provider of A

SEC EDGAR 8-K3 min